Literature DB >> 9922366

Chloroquine cardiomyopathy with conduction disorders.

J P Baguet1, F Tremel, M Fabre.   

Abstract

A 58 year old woman on long term treatment with chloroquine for systemic lupus erythematosus presented with cardiac conduction disorders and heart failure with hypertrophic cardiomyopathy, which was confirmed by histology to be related to chloroquine toxicity. The heart failure improved on stopping chloroquine treatment.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9922366      PMCID： PMC1728937          DOI： 10.1136/hrt.81.2.221

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  12 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

Review 2.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

3.  Cardiotoxicity after low-dose chloroquine antimalarial therapy.

Authors:  Gabriele Fragasso; Francesca Sanvito; Francesca Baratto; Sabina Martinenghi; Claudio Doglioni; Alberto Margonato
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

Review 4.  Drug-induced cardiovascular disorders.

Authors:  C Aengus Murphy; Henry J Dargie
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

Review 6.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

7.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

8.  A case of chloroquine-induced cardiomyopathy that presented as sick sinus syndrome.

Authors:  Jae Hak Lee; Woo-Baek Chung; Ju Hyun Kang; Hyung Woo Kim; Jin Jin Kim; Ji Hyun Kim; Hui-Jeong Hwang; Jea Beom Lee; Jong Won Chung; Hyo Lim Kim; Yun Seok Choi; Chul Soo Park; Ho-Joong Youn; Man Young Lee
Journal:  Korean Circ J       Date:  2010-11-30       Impact factor: 3.243

Review 9.  Cardiac effects and toxicity of chloroquine: a short update.

Authors:  Kanigula Mubagwa
Journal:  Int J Antimicrob Agents       Date:  2020-06-19       Impact factor: 5.283

10.  Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Authors:  A Nandagudi; E C Jury; D Alonzi; T D Butters; S Hughes; D A Isenberg
Journal:  Lupus       Date:  2013-07-17       Impact factor: 2.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.